Herbs (Global Traditional) · European
Solidago virgaurea
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Solidago virgaurea (European goldenrod) is a medicinal herb containing saponins, flavonoids, and phenolic acids that primarily exhibits anti-inflammatory and antimicrobial properties. The plant works through inhibition of inflammatory mediators and demonstrates potential activity against oral pathogens and cancer cell lines.
Solidago virgaurea (European goldenrod) is a perennial herb from the Asteraceae family native to Europe, Asia, and North America. The aerial parts, especially leaves and flowering tops, are harvested and processed using water-soluble extraction methods, with the active cytotoxic fraction isolated via Sephadex G-100 column chromatography yielding a 40,000 molecular weight component.
Human clinical evidence is extremely limited, with only one randomized, double-blind trial (n=22) examining S. virgaurea extract in toothpaste for oral candidiasis, showing modest improvements in oral symptoms after 2-3 weeks. Most research remains preclinical, including in vitro tumor cytotoxicity studies and rat cardiotoxicity models at 250 mg/kg doses. No PMIDs were provided in the research dossier.
Clinical dosing data is sparse. The only human study used S. virgaurea extract in toothpaste applied twice daily for 2-3 weeks (exact extract amount unspecified). Animal studies used 250 mg/kg orally in rats and 5 mg/kg injections in mice. No standardized human oral dosages have been established. Consult a healthcare provider before starting any new supplement.
Solidago virgaurea (European Goldenrod) is a medicinal herb rather than a dietary food source, so conventional macronutrient profiling is limited; it is not consumed in meaningful caloric quantities. Key bioactive compounds are the primary nutritional-pharmacological focus: Flavonoids: rutin (quercetin-3-rutinoside) reported at approximately 0.5–1.5% dry weight, quercetin, kaempferol, and isorhamnetin glycosides; these are the dominant polyphenolic constituents. Saponins: oleanolic acid and its glycosides (virgaureasaponins 1–6) at approximately 2–5% dry weight in aerial parts, along with leiocarposide and solidagosaponins — these are considered primary bioactive drivers. Phenolic acids: chlorogenic acid, caffeic acid, and hydroxycinnamic acid derivatives present at approximately 0.5–2% dry weight. Diterpenes: including solidagenone and related kaurane-type diterpenes. Tannins: hydrolysable and condensed tannins at approximately 5–10% in aerial parts. Essential oil: trace quantities (0.1–0.5%), containing alpha-pinene, limonene, and germacrene D. Inulin-type fructooligosaccharides present in roots. Fiber: present in plant matrix but not quantified for supplemental use. Vitamins and minerals: not characterized in therapeutic-grade extracts; not a meaningful dietary source. Bioavailability notes: Rutin has low oral bioavailability (~20%) unless hydrolyzed to quercetin in the gut; saponins may enhance permeability of co-administered compounds; standardized extracts typically normalized to flavonoid or saponin content for reproducibility.
Solidago virgaurea's bioactive compounds, particularly quercetin, rutin, and leiocarposide saponins, exert anti-inflammatory effects by inhibiting pro-inflammatory cytokines and cyclooxygenase pathways. The flavonoids demonstrate antimicrobial activity against Candida species through disruption of fungal cell membrane integrity. Phenolic compounds may induce apoptosis in cancer cells via oxidative stress pathways and cell cycle arrest.
Clinical evidence for Solidago virgaurea remains limited to one small trial of 22 participants examining its effects in toothpaste formulation for oral candidiasis. This study showed improvements in gum irritation and bleeding symptoms, though the evidence quality is low due to small sample size. Preclinical laboratory studies have demonstrated cytotoxic effects against prostate and breast cancer cell lines, but no human cancer trials exist. Most research consists of in vitro studies examining antimicrobial and anti-inflammatory properties.
Solidago virgaurea is generally well-tolerated when used topically or as directed, with no serious adverse events reported in available studies. Potential allergic reactions may occur in individuals sensitive to plants in the Asteraceae family, including ragweed or chrysanthemums. No significant drug interactions have been documented, though theoretical interactions with anticoagulant medications are possible due to flavonoid content. Safety during pregnancy and breastfeeding has not been established through clinical studies.
